EYEG Insider Trading Activity and SEC Form 4 Filings
EYEG insider trading summary
No open-market insider purchases or sales of Eyegate Pharmaceuticals Inc (EYEG) have been reported on SEC Form 4 in the past 12 months.
Latest EYEG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 2, 2021 | Armistice Capital, LLC | 10% Owner | Sell | $463K (192,775 @ $2.40) |
| Aug 2, 2021 | Armistice Capital Master Fund Ltd. | 10% Owner | Sell | $463K (192,775 @ $2.40) |
| Aug 2, 2021 | Steven Boyd | 10% Owner | Sell | $463K (192,775 @ $2.40) |
| Jul 30, 2021 | Armistice Capital, LLC | 10% Owner | Sell | $184K (68,188 @ $2.69) |
| Jul 30, 2021 | Armistice Capital Master Fund Ltd. | 10% Owner | Sell | $184K (68,188 @ $2.69) |
| Jul 30, 2021 | Steven Boyd | 10% Owner | Sell | $184K (68,188 @ $2.69) |
| Jul 29, 2021 | Armistice Capital, LLC | Director | Sell | $1.2M (400,000 @ $3.00) |
| Jul 29, 2021 | Armistice Capital Master Fund Ltd. | Director | Sell | $1.2M (400,000 @ $3.00) |
| Jul 29, 2021 | Steven Boyd | Director | Sell | $1.2M (400,000 @ $3.00) |
| Jul 28, 2021 | Steven Boyd | Director | Sell | $1.2M (375,443 @ $3.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.